Literature DB >> 3049146

Measuring health status in chronic airflow limitation.

G Guyatt1.   

Abstract

A health status instrument for use in clinical trials must be valid (measuring what it is supposed to measure) and responsive (able to detect clinically important change). Approaches to measuring health status in clinical trials include using a battery of instruments, a general instrument which provides a profile of the patient's health, an instrument that generates a health utility, or an instrument that focuses on the problems associated with a particular disease. Disease-specific instruments have been used in clinical trials in chronic airflow limitation (CAL). The Oxygen Cost Diagram is simple and easy to administer, but responsiveness and validity are unproven. The Transition Dyspnoea Index is valid and responsive, but is difficult to use in trials in which multiple measurements are desired. The Chronic Respiratory Disease Questionnaire has proved valid and responsive in controlled trials in CAL patients. Health status measures should be included in all clinical trials in CAL.

Entities:  

Mesh:

Year:  1988        PMID: 3049146

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Health-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instruments.

Authors:  R Desikan; H L Mason; M T Rupp; M Skehan
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

2.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

3.  A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease.

Authors:  Kathleen W Wyrwich; William M Tierney; Ajit N Babu; Kurt Kroenke; Fredric D Wolinsky
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

4.  Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.

Authors:  P J Wijkstra; E M Ten Vergert; R van Altena; V Otten; J Kraan; D S Postma; G H Koëter
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

5.  Reliability and validity of the chronic respiratory questionnaire (CRQ).

Authors:  P J Wijkstra; E M TenVergert; R Van Altena; V Otten; D S Postma; J Kraan; G H Koëter
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

6.  Reliability and Validity of the Functional Outcomes of Sleep Questionnaire - Spanish Short Version (FOSQ-10SV) in Peruvian Patients With Obstructive Sleep Apnea.

Authors:  Jorge Rey de Castro; Edmundo Rosales-Mayor; Terri E Weaver
Journal:  J Clin Sleep Med       Date:  2018-04-15       Impact factor: 4.062

7.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Authors:  Mona Bafadhel; Susan McKenna; Sarah Terry; Vijay Mistry; Mitesh Pancholi; Per Venge; David A Lomas; Michael R Barer; Sebastian L Johnston; Ian D Pavord; Christopher E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

8.  The role of CT scanning in multidimensional phenotyping of COPD.

Authors:  Mona Bafadhel; Imran Umar; Sumit Gupta; J Vimal Raj; Dhiraj D Vara; James J Entwisle; Ian D Pavord; Christopher E Brightling; Salman Siddiqui
Journal:  Chest       Date:  2011-03-31       Impact factor: 9.410

9.  Physician-estimated disease severity in patients with chronic heart or lung disease: a cross-sectional analysis.

Authors:  Kurt Kroenke; Kathleen W Wyrwich; William M Tierney; Ajit N Babu; Fredric D Wolinsky
Journal:  Health Qual Life Outcomes       Date:  2006-09-13       Impact factor: 3.186

10.  A pilot study: mindfulness meditation intervention in COPD.

Authors:  Roxane Raffin Chan; Nicholas Giardino; Janet L Larson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.